CHI3L1 and obstructive sleep apnea syndrome: Subjects with OSA had a 2.3 times higher concentration of YKL-40 in the serum, a 3.7 times higher concentration of CT-1, and a 77% lower concentration of OPG compared to the non-OSA control group.